Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-11 Sale | 2023-05-15 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 949 | $9.872 | $9,369 | 106,610 (Direct) | View |
| 2023-03-03 Sale | 2023-03-06 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 184 | $8.89 | $1,636 | 202,059 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 4,287 | $9.6653 | $41,435 | 76,243 (Direct) | View |
| 2023-01-10 Sale | 2023-01-12 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 1,752 | $8.1601 | $14,296 | 80,530 (Direct) | View |
| 2022-12-05 Sale | 2022-12-06 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 193 | $10.23 | $1,974 | 82,282 (Direct) | View |
| 2022-09-06 Sale | 2022-09-08 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 192 | $15.01 | $2,882 | 82,475 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:45 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 1,527 | $11.54 | $17,617 | 82,667 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 4:15 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 767 | $17.33 | $13,290 | 84,194 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:17 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 1,744 | $25.7 | $44,821 | 31,462 (Direct) | View |
| 2021-08-09 Sale | 2021-08-10 4:33 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 2,500 | $60 | $150,000 | 143,735 (Direct) | View |
| 2021-06-28 Sale | 2021-06-30 4:11 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 2,500 | $50 | $125,000 | 146,235 (Direct) | View |
| 2021-01-12 Sale | 2021-01-13 4:11 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 1,568 | $78.27 | $122,727 | 18,432 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-18 Option Award | 2024-06-20 8:31 pm | N/A 2034-06-18 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 20,833 | $0 | 20,833 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:10 pm | N/A 2033-09-24 | GERON CORP | GERN | ROBERTSON MICHELLE EVP, Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-13 6:10 pm | N/A 2034-03-11 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 5,291 | $0 | 5,291 (Direct) | View |
| 2024-03-11 Disposition | 2024-03-13 6:10 pm | N/A 2031-11-15 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 5,291 | $0 | 5,291 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:08 pm | N/A 2034-02-13 | GERON CORP | GERN | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-09-25 Option Award | 2023-09-27 7:31 pm | N/A 2033-09-24 | GERON CORP | GERN | ROBERTSON MICHELLE EVP, Chief Financial Officer | 1,350,000 | $0 | 1,350,000 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 4:32 pm | N/A 2033-05-15 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:30 pm | N/A 2033-03-01 | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 126,000 | $0 | 202,059 (Direct) | View |
| 2022-05-12 Option Award(A) | 2022-12-20 4:08 pm | N/A 2032-05-12 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:09 pm | N/A 2032-06-22 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-11 4:20 pm | N/A 2032-02-09 | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER | 211,079 | $0 | 242,541 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-23 4:09 pm | N/A N/A | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 4,471 | $0 | 33,206 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 06:10 am | N/A 2031-11-15 | Verastem Inc. | VSTM | ROBERTSON MICHELLE Director | 63,493 | $0 | 63,493 (Direct) | View |
| 2021-08-09 Exercise | 2021-08-10 4:33 pm | N/A N/A | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 2,500 | $30.65 | 143,735 (Direct) | View |
| 2021-08-09 Exercise | 2021-08-10 4:33 pm | N/A 2030-01-08 | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 2,500 | $0 | 143,735 (Direct) | View |
| 2021-06-28 Exercise | 2021-06-30 4:11 pm | N/A N/A | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 2,500 | $30.65 | 146,235 (Direct) | View |
| 2021-06-28 Exercise | 2021-06-30 4:11 pm | N/A 2030-01-08 | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 2,500 | $0 | 146,235 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 4:19 pm | N/A 2031-03-01 | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 42,500 | $0 | 60,932 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-10 4:05 pm | N/A 2030-01-08 | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 140,000 | $0 | 140,000 (Direct) | View |
Ownership | 2020-01-10 4:03 pm | N/A N/A | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer | 0 | $0 | 0 (Direct) | View |